Kenneth R. Hande - Concepedia

Author

Kenneth R. Hande

Also Known As

K Hande, K R Hande, K. Hande, K. R. Hande, K.R Hande, K.R. Hande, KENNETH R. HANDE, Kenneth Hande, Kenneth R Hande, Kenneth R. Hande

163

Publications

8.8K

Citations

H-Index

135

Concepts

All Affiliations

Vanderbilt University Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center Nashville VA Medical Center National Cancer Institute

About

Kenneth R. Hande is an author at Vanderbilt University specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	57	4.6K
2	Health Sciences	9	9	555
3	Natural Sciences	5	5	275
4	Public Health	3	3	181
5	Anesthesia	1	1	75

Kenneth R. Hande

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Severe allopurinol toxicity Kenneth R. Hande, Richard M. Noone, William J. Stone The American Journal of Medicine MedicineForensic ToxicologyPoisoningToxicologyPharmacotherapy	1984	668
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules George D. Demetri, Sant P. Chawla, Margaret von Mehren, Journal of Clinical Oncology	2009	524
Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity Ronald G. Stoller, Kenneth R. Hande, Samuel A. Jacobs, New England Journal of Medicine Drug SafetyStandard DeviationsPharmacokinetic ModelingMedicineHematology	1977	395
Chromosome 19 Translocation, Overexpression of Notch3, and Human Lung Cancer T. P. Dang, Adi F. Gazdar, A K Virmani, JNCI Journal of the National Cancer Institute CytogeneticsGeneticsChromosomal De-letionsPathologyGene Amplifi-cations	2000	255
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. Alan F. List, John D. Hainsworth, Ben W. Davis, Journal of Clinical Oncology PathologyPharmacotherapyMetronomic ChemotherapyPatients Profound HyponatremiaInappropriate Secretion	1986	219
Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial. David H. Johnson, F. Anthony Greco, John Strupp, Journal of Clinical Oncology OncologyPhase Ii TrialCancer ManagementPharmacologyOral Etoposide	1990	219
Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients. Kenneth R. Hande, P J Wedlund, Richard M. Noone, PubMed Therapeutic Drug MonitoringUrologyMedicineChronic Kidney DiseasePharmacology	1984	150
Bioavailability of low-dose oral etoposide. Kenneth R. Hande, Mary G. Krozely, F. Anthony Greco, Journal of Clinical Oncology	1993	144
Combined small-cell and non-small-cell lung cancer. M D Mangum, F. Anthony Greco, John D. Hainsworth, Journal of Clinical Oncology Non-small-cell Lung CancerAdvanced Lung DiseaseCancer DetectionMedicineCombined Subtype Histology	1989	142
Topoisomerase II inhibitors Kenneth R. Hande Update on Cancer Therapeutics Medicinal ChemistryMedicinePharmacotherapyAnti-cancer AgentDrug Development	2008	136

Page 1